Next Article in Journal
Running Loose or Getting Lost: How HIV-1 Counters and Capitalizes on APOBEC3-Induced Mutagenesis through Its Vif Protein
Next Article in Special Issue
Prion Disease and the Innate Immune System
Previous Article in Journal
Influenza B-Cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines

Cellular Prion Protein: From Physiology to Pathology

Division of Microbiology, National Institute of Health Sciences, Tokyo, Japan
Author to whom correspondence should be addressed.
Current Address: Roche Diagnostics Deutschland GmbH, Mannheim, Germany
Viruses 2012, 4(11), 3109-3131;
Received: 30 September 2012 / Revised: 5 November 2012 / Accepted: 6 November 2012 / Published: 14 November 2012
(This article belongs to the Special Issue Recent Developments in the Prion Field)
The human cellular prion protein (PrPC) is a glycosylphosphatidylinositol (GPI) anchored membrane glycoprotein with two N-glycosylation sites at residues 181 and 197. This protein migrates in several bands by Western blot analysis (WB). Interestingly, PNGase F treatment of human brain homogenates prior to the WB, which is known to remove the N-glycosylations, unexpectedly gives rise to two dominant bands, which are now known as C-terminal (C1) and N-terminal (N1) fragments. This resembles the β-amyloid precursor protein (APP) in Alzheimer disease (AD), which can be physiologically processed by α-, β-, and γ-secretases. The processing of APP has been extensively studied, while the identity of the cellular proteases involved in the proteolysis of PrPC and their possible role in prion biology has remained limited and controversial. Nevertheless, there is a strong correlation between the neurotoxicity caused by prion proteins and the blockade of their normal proteolysis. For example, expression of non-cleavable PrPC mutants in transgenic mice generates neurotoxicity, even in the absence of infectious prions, suggesting that PrPC proteolysis is physiologically and pathologically important. As many mouse models of prion diseases have recently been developed and the knowledge about the proteases responsible for the PrPC proteolysis is accumulating, we examine the historical experimental evidence and highlight recent studies that shed new light on this issue. View Full-Text
Keywords: neurodegenerative disease; prion; proteolytic cleavage; C1 neurodegenerative disease; prion; proteolytic cleavage; C1
Show Figures

Figure 1

MDPI and ACS Style

Yusa, S.-i.; Oliveira-Martins, J.B.; Sugita-Konishi, Y.; Kikuchi, Y. Cellular Prion Protein: From Physiology to Pathology. Viruses 2012, 4, 3109-3131.

AMA Style

Yusa S-i, Oliveira-Martins JB, Sugita-Konishi Y, Kikuchi Y. Cellular Prion Protein: From Physiology to Pathology. Viruses. 2012; 4(11):3109-3131.

Chicago/Turabian Style

Yusa, Sei-ichi, José B. Oliveira-Martins, Yoshiko Sugita-Konishi, and Yutaka Kikuchi. 2012. "Cellular Prion Protein: From Physiology to Pathology" Viruses 4, no. 11: 3109-3131.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop